Elo Mutual Pension Insurance Co Boosts Biogen Stake

Investment firm increases holdings in biotech company by 20.5% in Q3 2025

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

Elo Mutual Pension Insurance Co, an institutional investor, increased its stake in Biogen Inc. (NASDAQ:BIIB) by 20.5% in the third quarter of 2025. The firm now owns 21,602 shares of the biotechnology company's stock, valued at $3.03 million.

Why it matters

Biogen is a major player in the biotech industry, particularly in the development of therapies for neurological and neurodegenerative diseases. Institutional investors' holdings in the company can provide insight into market sentiment and the perceived value of Biogen's pipeline and products.

The details

Elo Mutual Pension Insurance Co added 3,668 shares of Biogen to its portfolio in the third quarter, bringing its total holdings to 21,602 shares. The investment firm's position in Biogen is now valued at $3.03 million. Biogen's stock price has fluctuated in recent months, closing at $184.02 on Wednesday.

  • Elo Mutual Pension Insurance Co increased its Biogen holdings in the third quarter of 2025.

The players

Elo Mutual Pension Insurance Co

An institutional investor that manages pension funds.

Biogen Inc.

A multinational biotechnology company focused on developing therapies for neurological and neurodegenerative diseases.

Got photos? Submit your photos here. ›

The takeaway

Elo Mutual Pension Insurance Co's increased stake in Biogen suggests the investment firm sees value in the biotech company's pipeline and products, which could signal broader market confidence in Biogen's future performance.